Separate names with a comma.
Discussion in 'Medtronic' started by anonymous, Apr 28, 2016 at 10:27 PM.
Kendall brands for sure and likely a Chinese buyer.
Latest on MITG spin off?
Just heard this week that Neuro/Pain is being considered for a sell-off to private equity group out of California. Could be interesting. What probably be the best thing as they may be motivated to innovate.
Can you provide any additional info?
Heard they were planning to sell off the super dimension division. Has anyone else heard that?
No...I'm not going to be tracked and locked up for violating insider trading laws. I do have details on proposed sizing: Very few sales layoffs expected (possibly increase in field force, in select markets). Minimum of $1.5million sales required per representative. Clinical specialists will be significantly downsized. Must have minimum of $2.5 million per territory to support sales and clinical. Exceptions will be made in markets where CS drives 50%+ sales (have no idea how that will be tracked). Will be an interesting late Summer/early-Fall.
Is this for kyphon?
Such BS!!! dumb***, learn the insider trading laws. You are a real life Gordon Gekko! BTW, the minimum territory size you are quoting have been in place for some time.
In place, but not readily enforced. That is where things will change, when we aren't protected under the large Spine sales. And no discussion of selling off Kyphon, but will be reabsorbed in the spine rep bag
Why would they do that? Do you know the main call point for the Kyphon team? It is Interventional radiology. The spine reps do not have a clue on how to work in this area.